Heart Failure with Reduced Ejection Fraction

Heart failure is a condition where the heart can’t pump well enough to deliver oxygen to the organs effectively. Ejection fraction is a term used to describe the amount of blood pumped out compared with the total blood the heart can hold. In a healthy heart, 50-70% of blood is ejected with each heartbeat.

We are conducting a clinical research study of a new investigational drug for people who have heart failure with a reduced ejection fraction.

You may be eligible if you:

• Are between 18 and 75 years old
• Have heart failure
• Have an ejection fraction (LVEF) of 15% to 45%
• Are currently taking medication for heart failure

Volunteers must be able to complete multiple overnight stays at our phase 1 clinic for this study. There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and study-related medical exams at no cost. A stipend of up to $4,334 is available for participants who complete the study. No health insurance is required to participate.

For more information call

(904) 730-0166

Or sign up below, and our friendly staff will call you!

Heart Failure Clinical Research

Heart failure is a serious medical condition where the heart cannot effectively deliver enough oxygenated blood to the organs. It affects millions of Americans and may have debilitating symptoms including edema, shortness of breath, systemic inflammation, and reduced quality of life.

Even with the best available treatment, there is still a risk of serious complications. Reducing the amount of systemic inflammation may increase health outcomes for people with heart failure. We are conducting a research study for people with heart failure that will evaluate the effectiveness of an investigational drug on cardiovascular health outcomes.

You may be eligible if you:

• Are 18 or older
• Have heart failure
• Have a preserved or mildly reduced ejection fraction (LVEF >40%) documented by echocardiography within the past 12 months

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and study-related medical exams at no cost and a stipend for time and travel. No health insurance is required to participate.

 For more information call

(904) 730-0166

Or sign up below, and our friendly staff will call you!

Heart Failure Clinical Research

Heart failure is a serious medical condition where the heart cannot effectively deliver enough oxygenated blood to the organs. It affects millions of Americans and may have debilitating symptoms including edema, shortness of breath, systemic inflammation, and reduced quality of life. Even with the best available treatment, there is still a risk of serious complications. Reducing the amount of systemic inflammation may increase health outcomes for people with heart failure. We are conducting a research study for people with heart failure that will evaluate the effectiveness of an investigational drug on cardiovascular health outcomes.

You may be eligible if you:

• Are 18 or older
• Have heart failure
• Have a preserved or mildly reduced ejection fraction (LVEF >40%) documented by echocardiography within the past 12 months

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and study-related medical exams at no cost and a stipend for time and travel. No health insurance is required to participate. 

For more information call

(904) 209-0043

Or sign up below, and our friendly staff will call you!

Heart Failure Clinical Research

Heart failure is a serious medical condition where the heart cannot effectively deliver enough oxygenated blood to the organs. It affects millions of Americans and may have debilitating symptoms including edema, shortness of breath, systemic inflammation, and reduced quality of life. Even with the best available treatment, there is still a risk of serious complications. Reducing the amount of systemic inflammation may increase health outcomes for people with heart failure. We are conducting a research study for people with heart failure that will evaluate the effectiveness of an investigational drug on cardiovascular health outcomes.

You may be eligible if you:

• Are 18 or older
• Have heart failure
• Have a preserved or mildly reduced ejection fraction (LVEF >40%) documented by echocardiography within the past 12 months

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and study-related medical exams at no cost and a stipend for time and travel. No health insurance is required to participate. 

For more information call

(352) 341-2100

Or sign up below, and our friendly staff will call you!

Heart Failure with Reduced Ejection Fraction

Heart failure is a condition where the heart can’t pump well enough to deliver oxygen to the organs effectively. Ejection fraction is a term used to describe the amount of blood pumped out compared with the total blood the heart can hold. In a healthy heart, 50-70% of blood is ejected with each heartbeat.

We are conducting a clinical research study of a new investigational drug for people who have heart failure with a reduced ejection fraction.

You may be eligible if you:

• Are between 18 and 75 years old
• Have heart failure
• Have an ejection fraction (LVEF) of 15% to 45%
• Are currently taking medication for heart failure

Volunteers must be able to complete multiple overnight stays at our phase 1 clinic for this study. There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and study-related medical exams at no cost. A stipend of up to $4,334 is available for participants who complete the study. No health insurance is required to participate.

 For more information call

(352) 341-2100

Or sign up below, and our friendly staff will call you!